Mironid
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
John Arbuthnott Building, 161 Cathedral ...Website
www.mironid.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Mironid
Mironid is a dynamic biotechnology company focused on developing novel small-molecule therapeutics aimed at treating Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. The company is dedicated to addressing high unmet medical needs through innovative drug development programs targeting cAMP degrading phosphodiesterase enzymes. Led by an experienced team, Mironid emphasizes a patient-centric approach in its mission to transform the treatment landscape for affected individuals. Their commitment to scientific innovation positions them as a leader in the biopharma industry.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mironid your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mironid is spiking on competitors!
Click to see if Mironid had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Mironid, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Mironid has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Mironid recently announced quarterly report
Product Launch: Get notified when Mironid launches new products
Congratulate Masked Content for being promoted to Masked Content at Mironid
Funding: Get notified immidiatlly once Mironid has new funding data
Recommended Actions
Reach out to Masked Content who joined Mironid as Masked Content
Find 3 more new buyers
Compare Similar Companies to Mironid
Compare insights from companies similar to Mironid, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mironid
<$5M
11-50
Private
$52.2M
2015
N/A
Company Profile Activity
Activity Insights
Mironid is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mironid is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mironid.
Mironid financials insights
Gather financial insights about Mironid, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$6.2M
2026
Series B
$46M
Mironid Tech Stack
A closer look at the technologies used by Mironid
See more technologies
Mironid News & Media
Mironid Presents Translational Data in Oral Presentation at the European Renal Association Congress
Mironid Presents Translational Data in Oral Presentation at the European Renal Association CongressMironid appoints Dr Catherine Kelleher as Chief Medical Officer
Mironid appoints Dr Catherine Kelleher as Chief Medical OfficerMironid Extends Series A Funding; £35M Raised To Date
Mironid, a Glasgow, UK-based biopharmaceutical company developing small molecule therapeutics, extended its Series A funding. The round, which brought the total amount raised to date to £35M, was led by Roche Venture Fund with participation from existing investors Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, the University of Strathclyde, Scottish Enterprise and the European Investment Fund. […] The post Mironid Extends Series A Funding; £35M Raised To Date appeared first on Fin
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Mironid
Sign Up For FreeTo access detailed company insights
Mironid is a dynamic biotechnology company focused on developing novel small-molecule therapeutics aimed at treating Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. The company is dedicated to addressing high unmet medical needs through innovative drug development programs targeting cAMP degrading phosphodiester... Read More
